Cefepime is an antibiotic that fights bacteria. It is used to treat severe infections of the skin, lungs, stomach, urinary tract, and blood. It works by killing the bacteria that cause these problems.

This leaflet answers some common questions about Cefepime Alphapharm. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Cefepime is a β-lactam antibiotic that is cleared through the kidneys. Elimination of cefepime is considerably delayed in patients with impaired renal function, and cefepime has been reported to ...

Armed with positive phase 3 results, Venatorx has said it will file for approval its cefepime-taniborbactam combination with the FDA later this year for complicated urinary tract infections (cUTI ...

Cefepime is used to treat a wide variety of bacterial infections. Ceftazidime is used to treat a wide variety of bacterial infections. Ceftriaxone is used to treat a wide variety of bacterial ...

The frequency of neutropenia in patients receiving long-term cefepime therapy for osteomyelitis compared with that in patients receiving other antimicrobials was studied. A comparative case review ...

And the endorsement has come for an oral antibiotic that has been available in Europe for more than 40 years. It’s an odd set ...

Review the side-effects of Cefepime as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections.

Find all the commercial and brand names of generic drug called Cefepime. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, ...

A total of 11 men and 1 woman between the ages of 18 and 70 years (mean ± S.D., 33 ± 15 years) were included in the cefepime group. One of the 12 patients underwent two courses of cefepime ...